Electronic data capture

SCRI Announces a Collaboration with AstraZeneca Focused on Technology Enhancements & Innovative Operational Model to Advance Cancer Research

Retrieved on: 
Wednesday, February 28, 2024

Sarah Cannon Research Institute (SCRI), one of the world’s leading oncology research organizations conducting community-based clinical trials, announced today a collaboration with AstraZeneca, a global, science-led biopharmaceutical company, aimed at advancing innovative technology and operational synergies to enhance the delivery of oncology clinical trials.

Key Points: 
  • Sarah Cannon Research Institute (SCRI), one of the world’s leading oncology research organizations conducting community-based clinical trials, announced today a collaboration with AstraZeneca, a global, science-led biopharmaceutical company, aimed at advancing innovative technology and operational synergies to enhance the delivery of oncology clinical trials.
  • Working together, SCRI and AstraZeneca will implement modern solutions to accelerate clinical trial delivery timelines, reduce site burden, and enhance U.S. enrollment.
  • To date, this advancement is decreasing site-based data entry time, reducing manual labor, lowering monitoring costs, improving data quality, and accelerating clinical trial decision-making overall.
  • “Working with SCRI to enhance U.S. enrollment and streamline clinical trial data collection is a tremendous opportunity to increase the diversity of clinical trial participants in the U.S. and accelerate clinical trial delivery timelines.

Lindus Health Launches "All-In-One Metabolic CRO" Offering to Accelerate and Enhance Metabolic Clinical Trials

Retrieved on: 
Tuesday, March 5, 2024

This unique marriage of technology and services sets metabolic sponsors up to run faster, more patient-centric clinical trials.

Key Points: 
  • This unique marriage of technology and services sets metabolic sponsors up to run faster, more patient-centric clinical trials.
  • "Our All-in-One Metabolic CRO offering is designed to streamline study activities at every stage of research.
  • Lindus carries a site team with extensive resumes in the metabolic study execution that cover roles across PIs, CRCs, and more.
  • Lindus Health's all-encompassing Metabolic CRO offering empowers metabolic disease sponsors to run more timely and successful clinical trials while enhancing patient experience.

Greenlight Guru Finishes 2023 with Strong Momentum in Q4

Retrieved on: 
Wednesday, January 24, 2024

INDIANAPOLIS, Jan. 24, 2024 /PRNewswire-PRWeb/ -- Greenlight Guru, the leading provider of cloud-based quality and clinical software for MedTech companies, announces today strong results in Q4 and for the full year of 2023 as the company continues to enhance its product offerings and expand its customer base, particularly with large, global MedTech companies. Greenlight Guru acquired more than 300 new customers in 2023 and saw high rates of expansion from existing customers as the company released new updates to its software.

Key Points: 
  • Greenlight Guru acquired more than 300 new customers in 2023 and saw high rates of expansion from existing customers as the company released new updates to its software.
  • As part of its commitment to continuous improvement and customer advocacy, Greenlight Guru made several enhancements to its MedTech Suite of purpose-built products in Q4.
  • "Customer satisfaction is at the heart of our philosophy here," said Stanley Finkelshteyn, VP of Product at Greenlight Guru.
  • "We ended 2023 on a high note," said David DeRam, CEO of Greenlight Guru.

Greenlight Guru's MedTech Suite Named a Leader in G2 Winter 2024 Grid Report

Retrieved on: 
Tuesday, December 19, 2023

INDIANAPOLIS, Dec. 19, 2023 /PRNewswire-PRWeb/ -- Greenlight Guru, the leading provider of cloud-based quality and clinical software for MedTech companies, proudly announces today its recognition in the G2 Winter 2024 Grid Report. This marks the twentieth consecutive quarter for Greenlight Guru Quality as a Leader in the QMS category and a groundbreaking debut for Greenlight Guru Clinical (formerly SMART-TRIAL) as a Leader in the Electronic Data Capture (EDC) category.

Key Points: 
  • INDIANAPOLIS, Dec. 19, 2023 /PRNewswire-PRWeb/ -- Greenlight Guru , the leading provider of cloud-based quality and clinical software for MedTech companies, proudly announces today its recognition in the G2 Winter 2024 Grid Report.
  • Customer quotes from the G2 Winter 2024 Grid Report highlight the platform's ease of use and comprehensive QMS functionalities, underscoring its value in the MedTech sector.
  • Greenlight Guru Clinical also received significant accolades in G2's Winter 2024 rankings as a leader in the Electronic Data Capture (EDC) category.
  • Customer quotes from the G2 Winter 2024 Grid Report commend Greenlight Guru Clinical for its intuitive design, responsive support team, and continuous feature improvements, all tailored to the unique needs of the MedTech industry.

Pioneering Phase III Clinical Trial Investigates Multiple Potential Long-COVID Treatments

Retrieved on: 
Thursday, November 2, 2023

The trial was designed by researchers at McMaster University in Hamilton, Canada, and is aimed at addressing the persisting challenges posed by Long-COVID.

Key Points: 
  • The trial was designed by researchers at McMaster University in Hamilton, Canada, and is aimed at addressing the persisting challenges posed by Long-COVID.
  • As a multi-center study beginning with 1,500 patients, the trial will rigorously assess the efficacy of multiple potential treatment options – beginning with fluvoxamine and metformin – in alleviating the symptoms associated with Long-COVID.
  • The trial will leverage state-of-the-art data management via an EDC developed by Yonalink, to ensure the highest caliber of data integrity.
  • The new approach seeks to swiftly identify effective Long-COVID-19 treatments and assess comparative efficacy without compromising the rigorous standards of a randomized clinical trial.

uMotif CEO Steve Rosenberg, Visionary eClinical Technology Senior Executive and Innovator, Named to PharmaVoice 100 Most Influential, Inspiring People in Life Sciences

Retrieved on: 
Wednesday, September 20, 2023

BOSTON and LONDON, Sept. 20, 2023 /PRNewswire-PRWeb/ -- uMotif – one of the clinical research technology market's fastest growing companies – announced that CEO Steve Rosenberg has once again been voted one of the PharmaVoice 100 most influential and inspiring people in the global healthcare and life sciences industries. (Read Steve's profile here)

Key Points: 
  • (Read Steve's profile here )
    PharmaVoice100 honorees are selected from a pool of nominations submitted by readers and colleagues, and then evaluated by the PharmaVoice team.
  • With a career spanning 40+ years in software development, for the past 20 years Steve has guided companies to develop, commercialize and promote technologies that accelerate patient-centric clinical R&D.
  • Steve is known for his success in urging the life sciences industry to invest in clinical research technologies to gather vast amounts of high-quality data, to improve the conduct of clinical trials.
  • "This industry is a ground-breaking one capable of changing the world through science and technology," said Meagan Parrish, lead editor of PharmaVoice.

Prelude Unveils Offline: A Mobile App for Data Collection Without an Internet Connection

Retrieved on: 
Wednesday, August 23, 2023

AUSTIN, Texas, Aug. 23, 2023 /PRNewswire/ -- Prelude is proud to announce the release of Prelude Offline, a mobile app that enables researchers to collect compliant data electronically in areas with limited to no internet connection and subsequently sync the data to Prelude's EDC when an internet connection is re-established.

Key Points: 
  • AUSTIN, Texas, Aug. 23, 2023 /PRNewswire/ -- Prelude is proud to announce the release of Prelude Offline, a mobile app that enables researchers to collect compliant data electronically in areas with limited to no internet connection and subsequently sync the data to Prelude's EDC when an internet connection is re-established.
  • ), wildlife, GLP and Non-GLP studies when stable internet access is unavailable – challenges include data entry errors, manual transcription, and paper management.
  • When synced, electronically collected data within Offline is seamlessly entered into Prelude's Electronic Data Capture (EDC) system when connectivity is re-established.
  • Key Features and Benefits include:
    Offline Data Collection: Enter data on a mobile device in areas with limited to no internet connectivity; and sync to Prelude EDC for data review once a connection is available.

Global eClinical Solutions Market Report 2023: Increased Government Grants to Support Clinical Trials Drives Growth

Retrieved on: 
Wednesday, June 28, 2023

Global eClinical Solutions Market, by Pharma and Biopharma Companies, by Region, 2019-2032 (USD Billion)

Key Points: 
  • Global eClinical Solutions Market, by Pharma and Biopharma Companies, by Region, 2019-2032 (USD Billion)
    8.2.1.
  • Global eClinical Solutions Market, by Electronic Clinical Outcome Assessment (ECOA), by Region, 2019-2032 (USD Billion)
    8.4.1.
  • Global eClinical Solutions Market, by Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), by Region, 2019-2032 (USD Billion)
    8.6.1.
  • Global eClinical Solutions Market, by Clinical Trial Management Systems (CTMS), by Region, 2019-2032 (USD Billion)
    8.9.1.

Revolutionary Machine Learning Tool Transforms Clinical Trial Medical Coding

Retrieved on: 
Thursday, June 15, 2023

Today, SDC is proud to announce key enhancements to our services with the development of an innovative machine learning tool that is set to revolutionize Medical Coding for clinical trials.

Key Points: 
  • Today, SDC is proud to announce key enhancements to our services with the development of an innovative machine learning tool that is set to revolutionize Medical Coding for clinical trials.
  • "Our machine learning tool represents a significant leap forward in clinical trial medical coding," said Todd Bonta, Vice President, Clinical Data Management.
  • One of the key advantages of this machine learning model is its ability to centralize medical coding across multiple platforms.
  • From an operational standpoint, the implementation of this machine learning tool streamlines the coding process, reducing manual effort and enhancing efficiency for the coding team.

Cloudbyz Unveils Groundbreaking Electronic Data Capture Solution to Streamline Clinical Research and Accelerate Launch of New Therapies

Retrieved on: 
Wednesday, March 15, 2023

NAPERVILLE, Ill., March 15, 2023 /PRNewswire/ -- Cloudbyz, a leading provider of unified clinical trial management solutions, today announced the launch of its innovative Electronic Data Capture (EDC) product, Cloudbyz EDC 2.0 .

Key Points: 
  • NAPERVILLE, Ill., March 15, 2023 /PRNewswire/ -- Cloudbyz, a leading provider of unified clinical trial management solutions, today announced the launch of its innovative Electronic Data Capture (EDC) product, Cloudbyz EDC 2.0 .
  • The Cloudbyz EDC platform combines an intuitive user interface with advanced data security, intelligent data validation, real-time data monitoring, analytics, and compliance with global regulatory standards.
  • Key features of Cloudbyz EDC 2.0 include:
    Seamless Data Capture: A user-friendly interface that simplifies the collection, validation, analysis and management of clinical trial data in real-time.
  • Advanced Data Security: State-of-the-art encryption, access control, and audit trail to safeguard the integrity and confidentiality of sensitive research data.